Pharmaceutical Executive
Costs of pediatric clinical trials are on the rise -- but companies forge ahead.
Pharmaceutical Executive-03-21-2007
Pharmaceutical Executive
No surprises here: Medicare, emerging markets boost drug sales--but mostly generics.
Pharmaceutical Executive
Merger with Organon strengthens late-stage pipeline.
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: FDA Approves Novo Nordisk's Rybelsus and Roche’s Gazyva/Gazyvaro
2
Merck Planning $70 Billion Investment for US Expansion
3
Amazon and WeightWatchers Partner for DTC Weight Loss Medication Offerings
4
FDA Approves Tezspire as First Biologic Targeting TSLP for Chronic Rhinosinusitis With Nasal Polyps
5
